A recent study revealed how nearly 6 out of every 10 neighborhoods are located in close proximity of a cannabis dispensary.
Four years ago, Canada legalized cannabis for adult use. A recent study now shows that nearly 6 out of every 10 neighborhoods in the country are located within a 5-minute drive of a cannabis dispensary (1). By having such an abundance of dispensaries within reach, the study showed the high level of access accessible to users.
The study was published by Drug and Alcohol Review and was funded by Canadian Institutes of Health Research (2). Several universities and research institutions in Ottawa and Toronto helped gather the data needed. During the study, researchers found that over the four-year timespan, only 7% of retail cannabis stores closed.
“Over 4 years, per capita stores and per capita sales increased each year by an average of 122.3% and 91.7%, respectively, with larger increases in private versus public systems (4.01 times greater for per capita stores and 2.46 times greater for per capita sales),” the researchers said (1).
Several studies have shown encouraging signs in neighborhoods where legal cannabis dispensaries are established. The University of New Mexico (Albuquerque, New Mexico) performed a study in 2021 that revealed a fall in unemployment in Colorado counties where dispensaries opened post-legalization, compared to counties where dispensaries did not open (3).
Another 2021 study produced results that showed having more access through medical and recreational storefront dispensaries were associated with reduced opioid related death rates, especially with deaths involving synthetic opioids such as, fentanyl (4).
References
Ep 24, Part I: Data Transparency in Cannabis Testing with Yasha Khan
November 21st 2024Evan Friedmann interviews Yasha Khan, co-founder of MCR Labs, about his journey into the cannabis industry and his efforts to promote transparency and integrity in laboratory practices. Yasha discusses the origins of MCR Labs, which began in Massachusetts to meet the needs of the soon-to-be legal medical cannabis market. He explains the challenges faced, including result manipulation by labs and the impact on public health. Yasha's Freedom of Information Act (FOIA) project aimed to gather testing data from 37 states, revealed significant discrepancies in potency and mold results. Despite some states' reluctance to share data, Yasha has made much of this data public, leading to collaborative research and publications on various aspects of cannabis testing.
Assessing Cannabis as a Harm Reduction Strategy: Insights from a Large-Scale Study
November 19th 2024A New Zealand study aimed to assess cannabis use as a harm reduction tool. Findings highlight lifestyle factors, and suggest cannabis-focused harm reduction strategies in reducing other substance use such as alcohol.
Ep 23, Part III: Accreditation in the Cannabis Industry with Susan Audino
October 24th 2024In Part III of this episode, host Evan Friedmann is joined by Susan Audino, PhD, founder of S.A. Audino & Associates, LLC, and co-founder of Saturn Scientific, LLC, to examine the complexities of sampling in the cannabis industry, emphasizing the need for proper sampling plans, and methods.